Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel.
Araújo A, Barroso A, Parente B, Travancinha C, Teixeira E, Martelo F, Fernandes G, Paupério G, Queiroga H, Duarte I, da Costa JD, Soares M, Borralho P, Costa P, Chinita P, Almodôvar T, Barata F. Araújo A, et al. Among authors: teixeira e. Pulmonology. 2024 Mar-Apr;30(2):159-169. doi: 10.1016/j.pulmoe.2022.11.008. Epub 2023 Jan 29. Pulmonology. 2024. PMID: 36717296 Free article. Review.
Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).
Figueiredo A, Almeida MA, Almodovar MT, Alves P, Araújo A, Araújo D, Barata F, Barradas L, Barroso A, Brito U, Camacho E, Canário D, Cardoso T, Chaves A, Costa L, Cunha J, Duarte J, Estevinho F, Felizardo M, Fernandes JP, Ferreira L, Ferreira L, Fidalgo P, Freitas C, Garrido P, Gil N, Hasmucrai D, Jesus E, Lopes JA, de Macedo JE, Meleiro A, Neveda R, Nogueira F, Pantorotto M, Parente B, Pego A, Rocha M, Roque J, Santos C, Saraiva J, Silva E, Silva S, Simões S, Soares M, Teixeira E, Timóteo T, Hespanhol V. Figueiredo A, et al. Among authors: teixeira e. Pulmonology. 2020 Jan-Feb;26(1):10-17. doi: 10.1016/j.pulmoe.2019.06.001. Epub 2019 Oct 18. Pulmonology. 2020. PMID: 31630986 Free article.
Personalizing medicine: strategies for implementing the evaluation of anaplastic lymphoma kinase rearrangement in non-small-cell lung cancer in Portugal.
Araújo A, Coelho A, de Mello RA, Azevedo I, Soares M, Queiroga H, Teixeira E, Parente B, Barata F. Araújo A, et al. Among authors: teixeira e. Rev Port Pneumol. 2012 Sep-Oct;18(5):244-6. doi: 10.1016/j.rppneu.2012.04.011. Epub 2012 Jun 29. Rev Port Pneumol. 2012. PMID: 22748945 Free article. English, Portuguese. No abstract available.
Pemetrexed in second line treatment of non-small cell lung cancer - The portuguese experience.
Araújo A, Barata F, Parente B, Rego S, Teixeira E, Melo M, Queiroga H, Cunha J, Duarte J, Coelho A; Pelo Grupode Estudos do Cancro do Pulmão. Araújo A, et al. Among authors: teixeira e. Rev Port Pneumol. 2008 Jul;14 Suppl 2:S9-S20. doi: 10.1016/S0873-2159(15)30310-X. Rev Port Pneumol. 2008. PMID: 25967568 Free article. English, Portuguese.
MuTAR study, Phase II, open-label study of erlotinib (E) treatment in patients (pts) with locally advanced or metastatic non-small cell lung cancer (mNSCLC) who present activating mutations (MUT+) in the tyrosine kinase (TKI) domain of the epidermal growth factor receptor (EGFR), assessed the efficacy of 1L in Portuguese pts with mNSCLC EGFR Mut.
Barata F, Queiroga H, Teixeira E, Almodovar MT, Parente B, Soares M. Barata F, et al. Among authors: teixeira e. Rev Port Pneumol (2006). 2016 Sep-Oct;22(5):287-8. doi: 10.1016/j.rppnen.2016.03.009. Epub 2016 May 6. Rev Port Pneumol (2006). 2016. PMID: 27162148 Free article. Clinical Trial. No abstract available.
Results from phase II, open-label study of anti-tumoral activity of first-line erlotinib in advanced/metastatic NSCLC patients with EGFR activating mutations, in Portugal: The MuTAR study.
Barata F, Queiroga H, Teixeira E, Almodovar T, Soares M, Parente B, Mellidez JC, Alves P, Antunes A. Barata F, et al. Among authors: teixeira e. Pulmonology. 2021 Mar-Apr;27(2):175-177. doi: 10.1016/j.pulmoe.2020.08.007. Epub 2020 Sep 21. Pulmonology. 2021. PMID: 32972881 Free article. Clinical Trial. No abstract available.
Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice.
R Teixeira M, Oliveira J, Borralho P, O Fernandes MG, Almodovar T, Fernandes I, Macedo D, Ferreira A, Barroso A, Teixeira E, Machado JC. R Teixeira M, et al. Among authors: teixeira e. Acta Med Port. 2022 Sep 1;35(9):677-690. doi: 10.20344/amp.17680. Epub 2022 Jul 11. Acta Med Port. 2022. PMID: 35816050 Free article.
482 results